This post was originally published on this site
https://i-invdn-com.akamaized.net/trkd-images/LYNXMPEG7J16J_L.jpg
Shares of the company rose marginally on Thursday, paring their earlier losses, after the Wall Street Journal first reported the news.
Rival coronavirus vaccine makers such as Moderna (NASDAQ:MRNA) Inc and Pfizer (NYSE:PFE) are targeting recruiting up to 30,000 volunteers for their late-stage studies.
